Questions for the Investor Relations department can be submitted using the form below or email IR@Liquidia.com. For all other inquires please go to Contact Us.
This contact form is not intended for Adverse Event reporting. To report SUSPECTED ADVERSE REACTIONS, contact Liquidia Technologies, Inc. at 1-888-393-LQDA (5732) or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.